Spero Therapeutics logo

Spero Therapeutics

SPRO | NASDAQ
Chart Builder DCF Calculator
$0.93
-$0.07 (-6.99%)
At close: Nov 16, 2026, 3:59 PM ET
$0.93
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-6.99%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37.5
+5.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #598/1021 (Top 59%)

Key Statistics

Market Data

Market Cap $54.3M
1D Range
0.90 0.99
52W Range
0.90 2.98

Valuation (TTM)

PE -1.79
PB 69.52
EV/EBITDA -6.41

Valuation (NTM)

Forward PE 1.65
Forward PEG -0.00
Price Target $6.00
Loading financial charts...

Profile

Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant ...

Sector Healthcare
Industry Biotechnology
Employees 25
IPO Date Nov 2, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 16, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$6.00
Upside
+545.16%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.